In this video, Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will talk about the duration of dual antiplatelet therapy given after LAD stenting. Most of such patients are put on the combination of clopidogrel and aspirin during stenting. The dual antiplatelet drug should be re-evaluated every six months. After six months, if the patient is at low risk of bleeding and has tolerated the medicine then should be continued for more 18 months. After this, only aspirin can be continued.